Stay up to date with news and events
Hereditary Disease Foundation (HDF) conference 2024 – Day 1
August 11, 2024
The HDBuzz team was back in Boston this year to livetweet updates from the Milton Wexler Biennial Symposium hosted by the Hereditary Disease Foundation (HDF),…
Hereditary Disease Foundation (HDF) conference 2024 – Day 2
Welcome to Day 2 of the Hereditary Disease Foundation (HDF) conference! The morning was spent listening to an interview between a neurologist and their patient…
Blue skies for Skyhawk: Positive news from Phase 1 trial for SKY-0515
July 13, 2024
The stormy trial updates that hung over the Huntington’s disease (HD) field in 2021 have certainly parted, making way for the bright and clear forecast…
Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial
July 12, 2024
New data from uniQure, who developed a one-and-done gene therapy for Huntington’s disease (HD) called AMT-130, indicates that the drug is relatively safe and might…
Positive news from Wave Life Sciences SELECT-HD trial
June 27, 2024
On 25th June 2024, Wave Life Sciences shared the results of their SELECT-HD clinical trial. This trial tested a therapy called WVE-003, designed to only…